4 Result(s)

Article

Diagnostic performance of plasma pTau₂₁₇, pTau₁₈₁, Aβ_1-42 and Aβ_1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

Recently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performa...

Javier Arranz, Nuole Zhu, Sara Rubio-Guerra… in Alzheimer's Research & Therapy (2024)

Article

Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

Nuole Zhu, Miguel Santos-Santos, Ignacio Illán-Gala… in Translational Neurodegeneration (2023)

Article

The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

Cerebrospinal fluid (CSF) Aβ1–42 levels and the Aβ1–42/Aβ1–40 ratio are markers of amyloid pathology, but previous studies suggest that their levels might be influenced by additional pathophysiological processes.

Constance Delaby, Teresa Estellés, Nuole Zhu… in Alzheimer's Research & Therapy (2022)

Article

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

Astrocytes play an essential role in neuroinflammation and are involved in the pathogenesis of neurodenegerative diseases. Studies of glial fibrillary acidic protein (GFAP), an astrocytic damage marker, may he...

Nuole Zhu, Miguel Santos-Santos, Ignacio Illán-Gala… in Translational Neurodegeneration (2021)